Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Cell Reports|November 17, 2021
Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapyYiqun Zhang, Fengju Chen, Erin Pleasance, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous systemDerek Wong, Yaoqing Shen, Adrian B Levine, et al.
Molecular Genetics & Genomic Medicine|November 25, 2020
Matching methods in precision oncology: An introduction and illustrative exampleDeirdre Weymann, Janessa Laskin, Steven J M Jones, et al.
Molecular Genetics & Genomic Medicine|May 27, 2017
The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancersDeirdre Weymann, Janessa Laskin, Robyn Roscoe, et al.
BMC Medical Genomics|September 7, 2022
TMBur: a distributable tumor mutation burden approach for whole genome sequencingEmma Titmuss, Richard D Corbett, Scott Davidson, et al.
Journal of Community Genetics|November 29, 2021
Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer careDeirdre Weymann, Janessa Laskin, Steven J M Jones, et al.
The American Journal of Surgical Pathology|June 4, 2016
ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic TumorsAli H Alassiri, Rola H Ali, Yaoqing Shen, et al.
Cold Spring Harbor Molecular Case Studies|December 25, 2019
Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic <i>DPYD</i> structural variantElisa Majounie, Kathleen Wee, Laura M Williamson, et al.
Investigational New Drugs|January 8, 2020
Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysisJean-Michel Lavoie, Teresa Mitchell, Sung-Eun Lee, et al.
Cold Spring Harbor Molecular Case Studies|February 14, 2018
Molecular characterization of <i>ERBB2</i>-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive casesDaniel R Owen, Hui-Li Wong, Melika Bonakdar, et al.
Pageof 12